We were unable to process your request. Please try again later. If you continue to have this issue please contact email@example.com.
How common is asymptomatic bowel involvement in patients with peripheral or axial SpA? Can we use NSAIDs in these patients? What’s the difference between sulfasalazine and mesalamine? Hear what a rheumatologist should know about IBD!
Brought to you by GSK. Considering a treatment change for patients with active SLE? Learn about a treatment option for your patients at treatfortodayandtomorrow.com.
In this episode :20
Let’s start with some basics of IBD 4:11
If a patient has axSpA, what are the chances they’ll develop IBD? 5:14
What about silent disease? 7:32
When should we send our SpA patients to a GI specialist? 11:22
Two medications: budesonide and mesalamine 13:33
Brought to you by GSK. Consider the long-term impact of disease activity, flares and corticosteroid use on patients with active SLE. Learn more now at treatfortodayandtomorrow.com
This category of drugs – 5-ASA 16:26
A look at COX inhibitors 23:06
Selective inhibition with COX-2 seems to be an attractive option for IBD 28:47